International Forum on the Collection and Use of COVID‐19 Convalescent Plasma: Responses

Al‐Riyami, Arwa Z.; Burnouf, Thierry; Yazer, Mark H.; Triulzi, Darrell J.; Kumaş, Levent Tufan; Sağdur, Levent; Pelit, Nil Banu; Bazin, Renée; Hindawi, Salwa; Badawi, Maha; Patidar, Gopal Kumar; Pandey, Hem Chandra; Chaurasia, Rahul; Fachini, Roberta; Scuracchio, Patrícia; Wendel, Silvano; Ang, Ai Leen; Ong, Kiat Hoe; Young, Pampee P.; Ihalainen, Jarkko; Vierikko, Antti; Qiu, Yan; Yang, Ru; Xu, Hua; Rahimi‐Levene, Naomi; Shinar, Eilat; Izak, Marina; González, Carlos; Ferrari, David Martin; Cini, Paula Verónica; Aditya, Robby Nur; Sharma, Ratti Ram; Sachdev, Suchet; Hans, Rekha; Lamba, Divjot Singh; Nissen‐Meyer, Lise Sofie Haug; Devine, Dana V.; Lee, Cheuk Kwong; Leung, Jennifer N. S.; Tiberghien, Pierre; Gallian, Pierre; Morel, Pascal; Maamari, Khuloud Al; Alhinai, Zaid; Vrielink, H.; So‐Osman, Cynthia; Angelis, Vincenzo De; Berti, Pierluigi; Ostuni, Angelo; Marano, Giuseppe; Nevessignsky, Michel Toungouz; Ekiaby, Magdy El; Daly, James J.; Hoad, Veronica C.; Kim, Sinyoung; Berg, Karin van den; Vermeulen, Marion; Glatt, Tanya Nadia; Schäfer, Richard; Reik, Rita A.; Gammon, Richard R; Lopez, Melissa; Estcourt, Lise J; MacLennan, Sheila; Roberts, David; Louw, Vernon; Dunbar, Nancy M.

doi:10.1111/vox.13114

Cited by 2 publications

(2 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Early in the pandemic, the International Society of Blood Transfusion (ISBT) established a multidisciplinary working group, comprised of international transfusion experts, to review the impacts of COVID‐19 on blood systems and existing practices on CCP collection and use from donor, product and patient perspectives [ 11 , 16 , 17 , 18 ]. This survey aims to assess the impact of COVID‐19 pandemic on BEs and TMS around the world to summarize the experiences and provide guidance to prepare for future pandemics.…”

Section: Introductionmentioning

confidence: 99%

International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID‐19 pandemic

et al. 2022

Self Cite

View full text Add to dashboard Cite

Background and Objectives The coronavirus disease 2019 (COVID‐19) pandemic has impacted blood systems worldwide. Challenges included maintaining blood supplies and initiating the collection and use of COVID‐19 convalescent plasma (CCP). Sharing information on the challenges can help improve blood collection and utilization. Materials and Methods A survey questionnaire was distributed to International Society of Blood Transfusion members in 95 countries. We recorded respondents' demographic information, impacts on the blood supply, CCP collection and use, transfusion demands and operational challenges. Results Eighty‐two responses from 42 countries, including 24 low‐ and middle‐income countries, were analysed. Participants worked in national (26.8%) and regional (26.8%) blood establishments and hospital‐based (42.7%) institutions. CCP collection and transfusion were reported by 63% and 36.6% of respondents, respectively. Decreases in blood donations occurred in 70.6% of collecting facilities. Despite safety measures and recruitment strategies, donor fear and refusal of institutions to host blood drives were major contributing factors. Almost half of respondents working at transfusion medicine services were from large hospitals with over 10,000 red cell transfusions per year, and 76.8% of those hospitals experienced blood shortages. Practices varied in accepting donors for blood or CCP donations after a history of COVID‐19 infection, CCP transfusion, or vaccination. Operational challenges included loss of staff, increased workloads and delays in reagent supplies. Almost half of the institutions modified their disaster plans during the pandemic. Conclusion The challenges faced by blood systems during the COVID‐19 pandemic highlight the need for guidance, harmonization, and strengthening of the preparedness and the capacity of blood systems against future infectious threats.

show abstract

Section: Introductionmentioning

confidence: 99%

International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID‐19 pandemic

et al. 2022

Self Cite

View full text Add to dashboard Cite

show abstract

“…In the response to the COVID-19 pandemic, there were impressive responses nationally and internationally – from blood transfusion establishments and general health authorities. EBA, EU, ISBT, AABB, WHO responded quickly and international collaboration concerning collection of data started immediately [20] , [21] .…”

Section: Convalescent Plasma: International Covid-19 Pandemic Respons...mentioning

confidence: 99%

COVID-19 convalescent plasma: current status, lessons from the past and future perspectives

Hervig

Flesland

Nissen‐Meyer

2022

Transfusion and Apheresis Science

View full text Add to dashboard Cite

International Forum on the Collection and Use of COVID‐19 Convalescent Plasma: Responses

Abstract: CCP is collected for transfusion, and for compassionate use. Question 4Yes. Diagnosis of COVID-19 infection by a laboratory test result (Either PCR test positivity studied from the

Cited by 2 publications

References 22 publications

International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID‐19 pandemic

International Society of Blood Transfusion survey of experiences of blood banks and transfusion services during the COVID‐19 pandemic

COVID-19 convalescent plasma: current status, lessons from the past and future perspectives

Contact Info

Product

Resources

About